

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.20445083 |
| 2 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.98685777 |
| 3 | protein prenylation (GO:0018342) | 3.93790323 |
| 4 | prenylation (GO:0097354) | 3.93790323 |
| 5 | telomere maintenance via recombination (GO:0000722) | 3.90927397 |
| 6 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.87839783 |
| 7 | iron-sulfur cluster assembly (GO:0016226) | 3.75761783 |
| 8 | metallo-sulfur cluster assembly (GO:0031163) | 3.75761783 |
| 9 | DNA strand elongation (GO:0022616) | 3.72476474 |
| 10 | platelet dense granule organization (GO:0060155) | 3.68938329 |
| 11 | mitotic recombination (GO:0006312) | 3.64273975 |
| 12 | protein neddylation (GO:0045116) | 3.61682090 |
| 13 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.56366354 |
| 14 | DNA double-strand break processing (GO:0000729) | 3.55665736 |
| 15 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.41805726 |
| 16 | base-excision repair, AP site formation (GO:0006285) | 3.36785126 |
| 17 | proteasome assembly (GO:0043248) | 3.36670449 |
| 18 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.35847888 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 3.35410501 |
| 20 | GPI anchor metabolic process (GO:0006505) | 3.27696550 |
| 21 | GPI anchor biosynthetic process (GO:0006506) | 3.25474399 |
| 22 | DNA replication initiation (GO:0006270) | 3.25186587 |
| 23 | CENP-A containing nucleosome assembly (GO:0034080) | 3.22625784 |
| 24 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.19293064 |
| 25 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.18367835 |
| 26 | cytochrome complex assembly (GO:0017004) | 3.18095660 |
| 27 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16328856 |
| 28 | protein complex biogenesis (GO:0070271) | 3.13755662 |
| 29 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.13077669 |
| 30 | DNA demethylation (GO:0080111) | 3.08673652 |
| 31 | cytidine metabolic process (GO:0046087) | 3.06518415 |
| 32 | cytidine catabolic process (GO:0006216) | 3.06518415 |
| 33 | cytidine deamination (GO:0009972) | 3.06518415 |
| 34 | DNA deamination (GO:0045006) | 3.04863691 |
| 35 | chromatin remodeling at centromere (GO:0031055) | 3.04681381 |
| 36 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.04326464 |
| 37 | purine nucleobase biosynthetic process (GO:0009113) | 3.02885638 |
| 38 | cullin deneddylation (GO:0010388) | 3.02707824 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.99751833 |
| 40 | telomere maintenance via telomere lengthening (GO:0010833) | 2.97030144 |
| 41 | DNA unwinding involved in DNA replication (GO:0006268) | 2.96169303 |
| 42 | protein deneddylation (GO:0000338) | 2.96013816 |
| 43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.93412474 |
| 44 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.92003215 |
| 45 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.90288631 |
| 46 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.89245254 |
| 47 | mannosylation (GO:0097502) | 2.88514634 |
| 48 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.88224100 |
| 49 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.87261681 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87249294 |
| 51 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.86757179 |
| 52 | nucleobase biosynthetic process (GO:0046112) | 2.86276416 |
| 53 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.85823643 |
| 54 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.85290017 |
| 55 | formation of translation preinitiation complex (GO:0001731) | 2.84351479 |
| 56 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.83054168 |
| 57 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.83054168 |
| 58 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.82723363 |
| 59 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.82442769 |
| 60 | C-terminal protein lipidation (GO:0006501) | 2.80697472 |
| 61 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.80211879 |
| 62 | DNA replication-independent nucleosome organization (GO:0034724) | 2.80211879 |
| 63 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.78554507 |
| 64 | maturation of SSU-rRNA (GO:0030490) | 2.77846657 |
| 65 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.77783254 |
| 66 | NADH dehydrogenase complex assembly (GO:0010257) | 2.77783254 |
| 67 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.77783254 |
| 68 | negative regulation of telomere maintenance (GO:0032205) | 2.77661639 |
| 69 | DNA replication checkpoint (GO:0000076) | 2.76915984 |
| 70 | eosinophil chemotaxis (GO:0048245) | 2.73169013 |
| 71 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.72964953 |
| 72 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.72757994 |
| 73 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.72181250 |
| 74 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71425606 |
| 75 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.70229046 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 2.69795994 |
| 77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.69795994 |
| 78 | regulation of RIG-I signaling pathway (GO:0039535) | 2.69530581 |
| 79 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.69530411 |
| 80 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.69530411 |
| 81 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69146912 |
| 82 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69146912 |
| 83 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69146912 |
| 84 | peptidyl-histidine modification (GO:0018202) | 2.66169335 |
| 85 | DNA integration (GO:0015074) | 2.65118795 |
| 86 | cell wall macromolecule metabolic process (GO:0044036) | 2.63521111 |
| 87 | telomere organization (GO:0032200) | 2.63463426 |
| 88 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.62972114 |
| 89 | telomere maintenance (GO:0000723) | 2.62880243 |
| 90 | viral mRNA export from host cell nucleus (GO:0046784) | 2.62591915 |
| 91 | chaperone-mediated protein transport (GO:0072321) | 2.62415708 |
| 92 | C-terminal protein amino acid modification (GO:0018410) | 2.62131765 |
| 93 | respiratory electron transport chain (GO:0022904) | 2.61050021 |
| 94 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.60762327 |
| 95 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.60762327 |
| 96 | DNA dealkylation (GO:0035510) | 2.60579070 |
| 97 | protein-cofactor linkage (GO:0018065) | 2.59960118 |
| 98 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59641391 |
| 99 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.59184311 |
| 100 | ubiquinone biosynthetic process (GO:0006744) | 2.59136562 |
| 101 | histone mRNA metabolic process (GO:0008334) | 2.58920389 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.58832850 |
| 103 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.58587304 |
| 104 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.58587304 |
| 105 | hepatocyte apoptotic process (GO:0097284) | 2.57484153 |
| 106 | electron transport chain (GO:0022900) | 2.56232158 |
| 107 | termination of RNA polymerase III transcription (GO:0006386) | 2.56226486 |
| 108 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.56226486 |
| 109 | kinetochore organization (GO:0051383) | 2.55337647 |
| 110 | ubiquinone metabolic process (GO:0006743) | 2.55226231 |
| 111 | eosinophil migration (GO:0072677) | 2.52929687 |
| 112 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.52392891 |
| 113 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.52085304 |
| 114 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.51583216 |
| 115 | IMP metabolic process (GO:0046040) | 2.51285292 |
| 116 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.49705069 |
| 117 | negative regulation of ligase activity (GO:0051352) | 2.49705069 |
| 118 | seminiferous tubule development (GO:0072520) | 2.45004546 |
| 119 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.44139195 |
| 120 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.44108941 |
| 121 | viral transcription (GO:0019083) | 2.43580221 |
| 122 | signal peptide processing (GO:0006465) | 2.43158385 |
| 123 | ribosomal small subunit biogenesis (GO:0042274) | 2.41676859 |
| 124 | deoxyribonucleotide catabolic process (GO:0009264) | 2.40559293 |
| 125 | negative T cell selection (GO:0043383) | 2.39159901 |
| 126 | translational termination (GO:0006415) | 2.38300641 |
| 127 | activated T cell proliferation (GO:0050798) | 2.37263092 |
| 128 | L-fucose catabolic process (GO:0042355) | 2.35689172 |
| 129 | fucose catabolic process (GO:0019317) | 2.35689172 |
| 130 | L-fucose metabolic process (GO:0042354) | 2.35689172 |
| 131 | nucleoside salvage (GO:0043174) | 2.35442429 |
| 132 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.35412648 |
| 133 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.35398036 |
| 134 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.34861335 |
| 135 | inositol phosphate dephosphorylation (GO:0046855) | 2.34861335 |
| 136 | meiotic chromosome segregation (GO:0045132) | 2.34809961 |
| 137 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.34787818 |
| 138 | cell cycle G1/S phase transition (GO:0044843) | 2.34787818 |
| 139 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.34771707 |
| 140 | necroptotic process (GO:0070266) | 2.34391932 |
| 141 | positive regulation of B cell differentiation (GO:0045579) | 2.32900693 |
| 142 | tryptophan metabolic process (GO:0006568) | 2.32576938 |
| 143 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.31854768 |
| 144 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.31854768 |
| 145 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.31080481 |
| 146 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.31029630 |
| 147 | B cell mediated immunity (GO:0019724) | 2.31016163 |
| 148 | spliceosomal snRNP assembly (GO:0000387) | 2.30960268 |
| 149 | purine-containing compound salvage (GO:0043101) | 2.28317799 |
| 150 | cotranslational protein targeting to membrane (GO:0006613) | 2.27738446 |
| 151 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.26906458 |
| 152 | kinetochore assembly (GO:0051382) | 2.26356403 |
| 153 | histone exchange (GO:0043486) | 2.26001539 |
| 154 | IMP biosynthetic process (GO:0006188) | 2.25952830 |
| 155 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.24109095 |
| 156 | protein targeting to ER (GO:0045047) | 2.23336042 |
| 157 | sequestering of actin monomers (GO:0042989) | 2.22847266 |
| 158 | translational elongation (GO:0006414) | 2.21917693 |
| 159 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.21620856 |
| 160 | regulation of B cell differentiation (GO:0045577) | 2.20707013 |
| 161 | immunoglobulin mediated immune response (GO:0016064) | 2.20223823 |
| 162 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.19214884 |
| 163 | negative regulation of phagocytosis (GO:0050765) | 2.18051800 |
| 164 | positive regulation of granulocyte differentiation (GO:0030854) | 2.17967342 |
| 165 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.17845637 |
| 166 | response to interferon-beta (GO:0035456) | 2.17645667 |
| 167 | protein localization to endoplasmic reticulum (GO:0070972) | 2.17517397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.81830256 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.90042557 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.23764774 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.23520727 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.19599639 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18388463 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.00475587 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98822708 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.92396947 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.83168429 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.82096331 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.73058640 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.62196480 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52261674 |
| 15 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51841497 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46879531 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.44430848 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.43561354 |
| 19 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.37830800 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29808015 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27293127 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.26683342 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25648885 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18780878 |
| 25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17131835 |
| 26 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.15960448 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13667300 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12908393 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09370291 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.06078002 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02281943 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.00640565 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.00253435 |
| 34 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00106011 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.99413372 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.96324762 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.94787737 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93973104 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93738162 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.91905499 |
| 41 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88489323 |
| 42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.87927903 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.86390102 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.84815554 |
| 45 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82863194 |
| 46 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82673259 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.78234916 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.78033738 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.77223668 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76578431 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75963762 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74967509 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73406512 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70667768 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68178088 |
| 56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66158467 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66154003 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64053055 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63150074 |
| 60 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.63067885 |
| 61 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62741827 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60282646 |
| 63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.59957021 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59804210 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59705159 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54401477 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54255924 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.52419798 |
| 69 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51650200 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45780203 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45714771 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43193651 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42430330 |
| 74 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41320327 |
| 75 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39662241 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37431757 |
| 77 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37414144 |
| 78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34870509 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34507801 |
| 80 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33612783 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33387873 |
| 82 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33106835 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32738283 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30374129 |
| 85 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29064732 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28355919 |
| 87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28317784 |
| 88 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28049726 |
| 89 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.27034414 |
| 90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26010672 |
| 91 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25589436 |
| 92 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25544572 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24252651 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23663494 |
| 95 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21244596 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.21184779 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20503522 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19205925 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19056191 |
| 100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.17893720 |
| 101 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17855602 |
| 102 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16702939 |
| 103 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16051104 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.15730647 |
| 105 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15376508 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14144689 |
| 107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13356650 |
| 108 | MYC_22102868_ChIP-Seq_BL_Human | 1.11211207 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10922892 |
| 110 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.10518814 |
| 111 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10111548 |
| 112 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09969933 |
| 113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08862363 |
| 114 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08143866 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.08025091 |
| 116 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07610649 |
| 117 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07610649 |
| 118 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07484228 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07042593 |
| 120 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.06868236 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05343515 |
| 122 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.03410542 |
| 123 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03029889 |
| 124 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03029889 |
| 125 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02729171 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02506900 |
| 127 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02415448 |
| 128 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02345722 |
| 129 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02345722 |
| 130 | MYB_26560356_Chip-Seq_TH2_Human | 1.02255000 |
| 131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01830718 |
| 132 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01172331 |
| 133 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00832068 |
| 134 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00112457 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99130068 |
| 136 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98572754 |
| 137 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95686570 |
| 138 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94074788 |
| 139 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93250244 |
| 140 | MYB_26560356_Chip-Seq_TH1_Human | 0.93066118 |
| 141 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92642362 |
| 142 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92450065 |
| 143 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.91549973 |
| 144 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91357646 |
| 145 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91234624 |
| 146 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91111688 |
| 147 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90688074 |
| 148 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90673799 |
| 149 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.90626620 |
| 150 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89787566 |
| 151 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89765254 |
| 152 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89487525 |
| 153 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89476346 |
| 154 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88784547 |
| 155 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87988723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.33232163 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.06159610 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 2.78661736 |
| 4 | MP0008057_abnormal_DNA_replication | 2.74189577 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.72483918 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.69143745 |
| 7 | MP0009697_abnormal_copulation | 2.62661060 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.59861014 |
| 9 | MP0002102_abnormal_ear_morphology | 2.50483998 |
| 10 | MP0008058_abnormal_DNA_repair | 2.44487087 |
| 11 | MP0005671_abnormal_response_to | 2.41086714 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.37031528 |
| 13 | MP0009785_altered_susceptibility_to | 2.30785513 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.25999366 |
| 15 | MP0005360_urolithiasis | 2.19471580 |
| 16 | MP0003077_abnormal_cell_cycle | 2.13508761 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.07891997 |
| 18 | MP0003186_abnormal_redox_activity | 2.06385025 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.05972777 |
| 20 | MP0005253_abnormal_eye_physiology | 2.05794718 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.04681514 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.03532557 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.97637139 |
| 24 | MP0003111_abnormal_nucleus_morphology | 1.93534483 |
| 25 | MP0005365_abnormal_bile_salt | 1.90539476 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.90429668 |
| 27 | MP0002132_abnormal_respiratory_system | 1.88439136 |
| 28 | MP0000685_abnormal_immune_system | 1.87206786 |
| 29 | MP0003787_abnormal_imprinting | 1.81429351 |
| 30 | MP0003436_decreased_susceptibility_to | 1.80013775 |
| 31 | MP0003880_abnormal_central_pattern | 1.79033062 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.77481971 |
| 33 | MP0001800_abnormal_humoral_immune | 1.73181108 |
| 34 | MP0004142_abnormal_muscle_tone | 1.72455651 |
| 35 | MP0001764_abnormal_homeostasis | 1.72305470 |
| 36 | MP0005025_abnormal_response_to | 1.69355958 |
| 37 | MP0006054_spinal_hemorrhage | 1.67696113 |
| 38 | MP0002398_abnormal_bone_marrow | 1.65741149 |
| 39 | MP0000490_abnormal_crypts_of | 1.61478243 |
| 40 | MP0008995_early_reproductive_senescence | 1.59057087 |
| 41 | MP0001529_abnormal_vocalization | 1.57271662 |
| 42 | MP0002006_tumorigenesis | 1.56892260 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.56015050 |
| 44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54775004 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.53683111 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.53648028 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.53605534 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.53096211 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.52726703 |
| 50 | MP0001984_abnormal_olfaction | 1.51537758 |
| 51 | MP0008789_abnormal_olfactory_epithelium | 1.50988877 |
| 52 | MP0002723_abnormal_immune_serum | 1.47779472 |
| 53 | MP0002722_abnormal_immune_system | 1.47518829 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.46240071 |
| 55 | MP0001819_abnormal_immune_cell | 1.45400025 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.44946459 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.44895742 |
| 58 | MP0002419_abnormal_innate_immunity | 1.43516059 |
| 59 | MP0001790_abnormal_immune_system | 1.43039194 |
| 60 | MP0005387_immune_system_phenotype | 1.43039194 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.40454111 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.40421891 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.39585459 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.39585459 |
| 65 | MP0000716_abnormal_immune_system | 1.37851928 |
| 66 | MP0002429_abnormal_blood_cell | 1.37243763 |
| 67 | MP0006082_CNS_inflammation | 1.37197664 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.36602465 |
| 69 | MP0009046_muscle_twitch | 1.35726411 |
| 70 | MP0001919_abnormal_reproductive_system | 1.35153775 |
| 71 | MP0005389_reproductive_system_phenotype | 1.34788049 |
| 72 | MP0002751_abnormal_autonomic_nervous | 1.33841332 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 1.32364717 |
| 74 | MP0006292_abnormal_olfactory_placode | 1.29699269 |
| 75 | MP0003786_premature_aging | 1.27959148 |
| 76 | MP0001853_heart_inflammation | 1.24985408 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.24464331 |
| 78 | MP0008469_abnormal_protein_level | 1.18608060 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.16094252 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.15694646 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.15684592 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.15432086 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 1.13561372 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 1.10705128 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 1.09135401 |
| 86 | MP0002019_abnormal_tumor_incidence | 1.07591982 |
| 87 | MP0006276_abnormal_autonomic_nervous | 1.07291045 |
| 88 | MP0000703_abnormal_thymus_morphology | 1.06001268 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.04106487 |
| 90 | MP0003303_peritoneal_inflammation | 1.04008945 |
| 91 | MP0002405_respiratory_system_inflammati | 1.03981044 |
| 92 | MP0003252_abnormal_bile_duct | 1.03769793 |
| 93 | MP0001188_hyperpigmentation | 1.02164955 |
| 94 | MP0005499_abnormal_olfactory_system | 1.01337660 |
| 95 | MP0005394_taste/olfaction_phenotype | 1.01337660 |
| 96 | MP0003011_delayed_dark_adaptation | 1.00020297 |
| 97 | MP0000371_diluted_coat_color | 0.97378173 |
| 98 | MP0003866_abnormal_defecation | 0.97037000 |
| 99 | MP0008872_abnormal_physiological_respon | 0.96963314 |
| 100 | MP0000598_abnormal_liver_morphology | 0.96029091 |
| 101 | MP0002272_abnormal_nervous_system | 0.95066898 |
| 102 | MP0001905_abnormal_dopamine_level | 0.94749619 |
| 103 | MP0001666_abnormal_nutrient_absorption | 0.94032013 |
| 104 | MP0003718_maternal_effect | 0.93311159 |
| 105 | MP0003724_increased_susceptibility_to | 0.93256305 |
| 106 | MP0002933_joint_inflammation | 0.92824072 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.91858455 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.91636962 |
| 109 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91426345 |
| 110 | MP0008932_abnormal_embryonic_tissue | 0.91423493 |
| 111 | MP0000858_altered_metastatic_potential | 0.91285335 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.90936514 |
| 113 | MP0000313_abnormal_cell_death | 0.89544965 |
| 114 | MP0002736_abnormal_nociception_after | 0.88101848 |
| 115 | MP0002163_abnormal_gland_morphology | 0.87728067 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.87160826 |
| 117 | MP0001929_abnormal_gametogenesis | 0.86371230 |
| 118 | MP0000609_abnormal_liver_physiology | 0.86248913 |
| 119 | MP0003122_maternal_imprinting | 0.85910027 |
| 120 | MP0000350_abnormal_cell_proliferation | 0.85240119 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.85036592 |
| 122 | MP0009763_increased_sensitivity_to | 0.84144951 |
| 123 | MP0003868_abnormal_feces_composition | 0.84049820 |
| 124 | MP0001873_stomach_inflammation | 0.82967268 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.82712720 |
| 126 | MP0005408_hypopigmentation | 0.81891928 |
| 127 | MP0005332_abnormal_amino_acid | 0.81874197 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.80832687 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.80690271 |
| 130 | MP0002160_abnormal_reproductive_system | 0.80612297 |
| 131 | MP0009764_decreased_sensitivity_to | 0.78433109 |
| 132 | MP0004147_increased_porphyrin_level | 0.77228655 |
| 133 | MP0004742_abnormal_vestibular_system | 0.76800183 |
| 134 | MP0001486_abnormal_startle_reflex | 0.76254178 |
| 135 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75968871 |
| 136 | MP0002638_abnormal_pupillary_reflex | 0.75326158 |
| 137 | MP0003121_genomic_imprinting | 0.75212295 |
| 138 | MP0006036_abnormal_mitochondrial_physio | 0.75095665 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.74835197 |
| 140 | MP0008877_abnormal_DNA_methylation | 0.72748452 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.71407174 |
| 142 | MP0001119_abnormal_female_reproductive | 0.67784709 |
| 143 | MP0010307_abnormal_tumor_latency | 0.67076065 |
| 144 | MP0000477_abnormal_intestine_morphology | 0.66049502 |
| 145 | MP0003195_calcinosis | 0.66042109 |
| 146 | MP0002075_abnormal_coat/hair_pigmentati | 0.65649338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 3.59750769 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47226277 |
| 3 | Methylmalonic acidemia (HP:0002912) | 3.34811628 |
| 4 | Aplastic anemia (HP:0001915) | 3.27743957 |
| 5 | IgM deficiency (HP:0002850) | 3.13737545 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.10037975 |
| 7 | Thrombocytosis (HP:0001894) | 3.06851723 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.05425790 |
| 9 | Stomach cancer (HP:0012126) | 3.05065003 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 2.97686901 |
| 11 | Mitochondrial inheritance (HP:0001427) | 2.93892821 |
| 12 | Myositis (HP:0100614) | 2.92754488 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.92345417 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 2.82375104 |
| 15 | Reticulocytopenia (HP:0001896) | 2.82134533 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81431762 |
| 17 | Increased CSF lactate (HP:0002490) | 2.75726337 |
| 18 | Birth length less than 3rd percentile (HP:0003561) | 2.75452430 |
| 19 | Progressive macrocephaly (HP:0004481) | 2.74458747 |
| 20 | Pancreatic cysts (HP:0001737) | 2.74181945 |
| 21 | Abnormality of B cell number (HP:0010975) | 2.74116896 |
| 22 | Methylmalonic aciduria (HP:0012120) | 2.73782100 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73440559 |
| 24 | Hepatocellular necrosis (HP:0001404) | 2.71470547 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 2.68358208 |
| 26 | Acute encephalopathy (HP:0006846) | 2.65124895 |
| 27 | Abnormal number of erythroid precursors (HP:0012131) | 2.63992759 |
| 28 | Type I transferrin isoform profile (HP:0003642) | 2.60611404 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.57598582 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 2.57333313 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56470254 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.54763011 |
| 33 | Colon cancer (HP:0003003) | 2.54443138 |
| 34 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51939492 |
| 35 | Prolonged partial thromboplastin time (HP:0003645) | 2.49602042 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.48951445 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 2.45310554 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 2.45310554 |
| 39 | Stomatitis (HP:0010280) | 2.42899436 |
| 40 | True hermaphroditism (HP:0010459) | 2.41530502 |
| 41 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.41280138 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.37280427 |
| 43 | Hyperglycinemia (HP:0002154) | 2.36468162 |
| 44 | Increased hepatocellular lipid droplets (HP:0006565) | 2.36151042 |
| 45 | Lactic acidosis (HP:0003128) | 2.35832148 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.35661878 |
| 47 | Increased serum lactate (HP:0002151) | 2.34971492 |
| 48 | Optic neuritis (HP:0100653) | 2.33707965 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.33707965 |
| 50 | Absent thumb (HP:0009777) | 2.33103081 |
| 51 | Petechiae (HP:0000967) | 2.33078980 |
| 52 | Orchitis (HP:0100796) | 2.31978349 |
| 53 | Oral leukoplakia (HP:0002745) | 2.31834016 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.31689793 |
| 55 | Hypothermia (HP:0002045) | 2.31255192 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.28888902 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.23561544 |
| 58 | Abnormality of the anterior horn cell (HP:0006802) | 2.22386258 |
| 59 | Degeneration of anterior horn cells (HP:0002398) | 2.22386258 |
| 60 | Chronic diarrhea (HP:0002028) | 2.19460922 |
| 61 | IgG deficiency (HP:0004315) | 2.19428852 |
| 62 | 3-Methylglutaconic aciduria (HP:0003535) | 2.18841453 |
| 63 | Intrahepatic cholestasis (HP:0001406) | 2.18552974 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.18380556 |
| 65 | Abnormality of eosinophils (HP:0001879) | 2.15723572 |
| 66 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15034239 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.15013865 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.14735392 |
| 69 | 11 pairs of ribs (HP:0000878) | 2.14497651 |
| 70 | Microretrognathia (HP:0000308) | 2.12564766 |
| 71 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12391507 |
| 72 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12391507 |
| 73 | Steatorrhea (HP:0002570) | 2.11991503 |
| 74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11400273 |
| 75 | Hypoplasia of the thymus (HP:0000778) | 2.11356943 |
| 76 | Renal cortical cysts (HP:0000803) | 2.10670763 |
| 77 | Encephalitis (HP:0002383) | 2.10374335 |
| 78 | Abnormal biliary tract physiology (HP:0012439) | 2.10340160 |
| 79 | Bile duct proliferation (HP:0001408) | 2.10340160 |
| 80 | Hypoproteinemia (HP:0003075) | 2.09763510 |
| 81 | Chromsome breakage (HP:0040012) | 2.09748212 |
| 82 | Fat malabsorption (HP:0002630) | 2.09117409 |
| 83 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08685078 |
| 84 | T lymphocytopenia (HP:0005403) | 2.08435567 |
| 85 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07112265 |
| 86 | Pancytopenia (HP:0001876) | 2.05997853 |
| 87 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.05953095 |
| 88 | Hyperalaninemia (HP:0003348) | 2.05827112 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.05827112 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.05827112 |
| 91 | Thyroiditis (HP:0100646) | 2.05316864 |
| 92 | Lymphoma (HP:0002665) | 2.04813591 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.04656491 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04341906 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04341906 |
| 96 | Agnosia (HP:0010524) | 2.04246138 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04002391 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 2.03587202 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.02039114 |
| 100 | Epistaxis (HP:0000421) | 2.01909850 |
| 101 | Cerebral edema (HP:0002181) | 2.01683388 |
| 102 | Abnormality of vitamin B metabolism (HP:0004340) | 2.00509849 |
| 103 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.00076133 |
| 104 | Broad alveolar ridges (HP:0000187) | 1.99333537 |
| 105 | Myelodysplasia (HP:0002863) | 1.98349205 |
| 106 | Combined immunodeficiency (HP:0005387) | 1.98252991 |
| 107 | Abnormal protein glycosylation (HP:0012346) | 1.97692053 |
| 108 | Abnormal glycosylation (HP:0012345) | 1.97692053 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.97692053 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.97692053 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.96742061 |
| 112 | Recurrent skin infections (HP:0001581) | 1.95532088 |
| 113 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.94710395 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94596594 |
| 115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94295212 |
| 116 | Abnormality of methionine metabolism (HP:0010901) | 1.94232671 |
| 117 | Abnormality of T cells (HP:0002843) | 1.94122951 |
| 118 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.93474508 |
| 119 | Optic disc pallor (HP:0000543) | 1.93057381 |
| 120 | B lymphocytopenia (HP:0010976) | 1.92932779 |
| 121 | Glossoptosis (HP:0000162) | 1.90699564 |
| 122 | Abnormality of the prostate (HP:0008775) | 1.90259280 |
| 123 | Nephronophthisis (HP:0000090) | 1.89375430 |
| 124 | Congenital primary aphakia (HP:0007707) | 1.88499431 |
| 125 | Abnormal platelet function (HP:0011869) | 1.87906311 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.87906311 |
| 127 | Recurrent viral infections (HP:0004429) | 1.87227436 |
| 128 | Delayed CNS myelination (HP:0002188) | 1.87156108 |
| 129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86917848 |
| 130 | Eosinophilia (HP:0001880) | 1.86615976 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86589547 |
| 132 | Opisthotonus (HP:0002179) | 1.86553813 |
| 133 | Abnormality of chromosome stability (HP:0003220) | 1.86400869 |
| 134 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.85994919 |
| 135 | Bone marrow hypocellularity (HP:0005528) | 1.85768552 |
| 136 | Dicarboxylic aciduria (HP:0003215) | 1.85507343 |
| 137 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85507343 |
| 138 | Abnormality of serum amino acid levels (HP:0003112) | 1.84920665 |
| 139 | Anorexia (HP:0002039) | 1.84590451 |
| 140 | Pallor (HP:0000980) | 1.84465445 |
| 141 | Abnormality of the labia minora (HP:0012880) | 1.83796541 |
| 142 | Ketoacidosis (HP:0001993) | 1.83602566 |
| 143 | Respiratory failure (HP:0002878) | 1.83544248 |
| 144 | Arterial thrombosis (HP:0004420) | 1.83205254 |
| 145 | Axonal loss (HP:0003447) | 1.83186564 |
| 146 | Lethargy (HP:0001254) | 1.82512335 |
| 147 | Sparse eyelashes (HP:0000653) | 1.82067127 |
| 148 | Joint hemorrhage (HP:0005261) | 1.81160249 |
| 149 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79209303 |
| 150 | Agammaglobulinemia (HP:0004432) | 1.78155754 |
| 151 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.78014737 |
| 152 | Gingival bleeding (HP:0000225) | 1.77933829 |
| 153 | Attenuation of retinal blood vessels (HP:0007843) | 1.77369753 |
| 154 | Large for gestational age (HP:0001520) | 1.77321748 |
| 155 | Ketosis (HP:0001946) | 1.76891751 |
| 156 | Progressive inability to walk (HP:0002505) | 1.76887010 |
| 157 | Amaurosis fugax (HP:0100576) | 1.76747901 |
| 158 | Neutropenia (HP:0001875) | 1.76711074 |
| 159 | Abnormality of glycine metabolism (HP:0010895) | 1.76584085 |
| 160 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76584085 |
| 161 | Vasculitis (HP:0002633) | 1.76192740 |
| 162 | CNS demyelination (HP:0007305) | 1.75744458 |
| 163 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75565498 |
| 164 | Short tibia (HP:0005736) | 1.75434650 |
| 165 | Ankle contracture (HP:0006466) | 1.74822002 |
| 166 | Poikiloderma (HP:0001029) | 1.74363472 |
| 167 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73923952 |
| 168 | Exertional dyspnea (HP:0002875) | 1.73363997 |
| 169 | Lymphopenia (HP:0001888) | 1.71867453 |
| 170 | Generalized aminoaciduria (HP:0002909) | 1.71227608 |
| 171 | Hyperlipoproteinemia (HP:0010980) | 1.71180047 |
| 172 | Gait imbalance (HP:0002141) | 1.70967229 |
| 173 | Microvesicular hepatic steatosis (HP:0001414) | 1.69466002 |
| 174 | Autoimmune hemolytic anemia (HP:0001890) | 1.69433354 |
| 175 | Prostate neoplasm (HP:0100787) | 1.68632390 |
| 176 | Eczematoid dermatitis (HP:0000976) | 1.68435729 |
| 177 | Hepatic necrosis (HP:0002605) | 1.68296198 |
| 178 | Hyperammonemia (HP:0001987) | 1.67857474 |
| 179 | Recurrent bronchitis (HP:0002837) | 1.66406658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK2 | 3.92793358 |
| 2 | ACVR1B | 3.80510466 |
| 3 | STK16 | 2.70158550 |
| 4 | WEE1 | 2.66632307 |
| 5 | MAP4K2 | 2.59914636 |
| 6 | TRIM28 | 2.57854373 |
| 7 | PIK3CG | 2.47178052 |
| 8 | EIF2AK1 | 2.34513148 |
| 9 | BRSK2 | 2.24309966 |
| 10 | TXK | 2.23704531 |
| 11 | ERBB3 | 2.19571679 |
| 12 | KIT | 2.16120332 |
| 13 | EIF2AK3 | 2.12561249 |
| 14 | CDC7 | 2.10676617 |
| 15 | BUB1 | 2.04193329 |
| 16 | MAP4K1 | 2.00602893 |
| 17 | WNK3 | 1.98977190 |
| 18 | FLT3 | 1.92415428 |
| 19 | NUAK1 | 1.88997784 |
| 20 | NME2 | 1.72756461 |
| 21 | IKBKE | 1.72357781 |
| 22 | SRPK1 | 1.70597589 |
| 23 | NEK9 | 1.68193322 |
| 24 | VRK1 | 1.68051848 |
| 25 | RPS6KA4 | 1.65259228 |
| 26 | BCKDK | 1.62238487 |
| 27 | STK24 | 1.61300176 |
| 28 | TGFBR1 | 1.60563353 |
| 29 | GRK1 | 1.59516982 |
| 30 | SIK3 | 1.57893131 |
| 31 | DYRK3 | 1.55988662 |
| 32 | IRAK4 | 1.50205456 |
| 33 | TYK2 | 1.48626339 |
| 34 | JAK3 | 1.47687779 |
| 35 | MAP3K12 | 1.45553820 |
| 36 | MAP3K4 | 1.43553851 |
| 37 | TEC | 1.42739720 |
| 38 | PASK | 1.42130891 |
| 39 | BTK | 1.41565952 |
| 40 | MAP3K14 | 1.39162125 |
| 41 | BMPR2 | 1.38458551 |
| 42 | STK38L | 1.33089784 |
| 43 | PINK1 | 1.31110267 |
| 44 | PLK4 | 1.30456548 |
| 45 | ZAP70 | 1.28440436 |
| 46 | ZAK | 1.26012170 |
| 47 | PLK2 | 1.22384396 |
| 48 | BLK | 1.21746882 |
| 49 | CAMKK2 | 1.21643189 |
| 50 | CSF1R | 1.20997174 |
| 51 | CSNK1A1L | 1.20410149 |
| 52 | TBK1 | 1.17678540 |
| 53 | ATR | 1.15916744 |
| 54 | CSNK1G1 | 1.14975988 |
| 55 | CSNK1G2 | 1.13939674 |
| 56 | ADRBK2 | 1.12881552 |
| 57 | IKBKB | 1.12478218 |
| 58 | FRK | 1.08476611 |
| 59 | CCNB1 | 1.08226898 |
| 60 | PIM2 | 1.07949742 |
| 61 | BRSK1 | 1.05888318 |
| 62 | MAP2K7 | 1.03966255 |
| 63 | FES | 1.02693321 |
| 64 | MYLK | 0.97849171 |
| 65 | VRK2 | 0.96596152 |
| 66 | MAP3K5 | 0.95715168 |
| 67 | PBK | 0.95163469 |
| 68 | PLK1 | 0.94462047 |
| 69 | PLK3 | 0.92537407 |
| 70 | CDK19 | 0.92470061 |
| 71 | AURKB | 0.90600497 |
| 72 | FGFR4 | 0.90444885 |
| 73 | PIM1 | 0.89959352 |
| 74 | SYK | 0.89315474 |
| 75 | TSSK6 | 0.88411310 |
| 76 | CDK8 | 0.87599115 |
| 77 | PDK2 | 0.86726323 |
| 78 | BMPR1B | 0.85068826 |
| 79 | LYN | 0.84596513 |
| 80 | KDR | 0.84049824 |
| 81 | MKNK1 | 0.83270385 |
| 82 | PRKCQ | 0.81841286 |
| 83 | TNIK | 0.77849595 |
| 84 | YES1 | 0.75723175 |
| 85 | CDK7 | 0.74588261 |
| 86 | MAPK13 | 0.74082148 |
| 87 | TLK1 | 0.73787256 |
| 88 | NEK1 | 0.71688438 |
| 89 | EIF2AK2 | 0.71097291 |
| 90 | STK10 | 0.70569954 |
| 91 | TAOK1 | 0.68916952 |
| 92 | INSRR | 0.68659785 |
| 93 | GRK6 | 0.67751032 |
| 94 | MAPK11 | 0.67490493 |
| 95 | ITK | 0.65129938 |
| 96 | SCYL2 | 0.64679449 |
| 97 | RPS6KB2 | 0.64523110 |
| 98 | CLK1 | 0.63314923 |
| 99 | NEK2 | 0.63271233 |
| 100 | NLK | 0.62918529 |
| 101 | PRKCE | 0.61588855 |
| 102 | FGFR3 | 0.61412932 |
| 103 | TGFBR2 | 0.60284656 |
| 104 | STK4 | 0.60008688 |
| 105 | DYRK1A | 0.59608619 |
| 106 | CSNK2A1 | 0.59206095 |
| 107 | LCK | 0.58504534 |
| 108 | TESK2 | 0.57345196 |
| 109 | MAP3K11 | 0.56824053 |
| 110 | GRK7 | 0.55437185 |
| 111 | DYRK2 | 0.54845780 |
| 112 | TAOK2 | 0.53466544 |
| 113 | TNK2 | 0.51684708 |
| 114 | RPS6KA6 | 0.51407143 |
| 115 | CSNK1G3 | 0.51091758 |
| 116 | GRK5 | 0.50991356 |
| 117 | CHUK | 0.49121282 |
| 118 | MAP3K10 | 0.48771055 |
| 119 | CHEK2 | 0.47670423 |
| 120 | EPHA3 | 0.47592861 |
| 121 | IGF1R | 0.47086990 |
| 122 | TESK1 | 0.47072525 |
| 123 | RPS6KA5 | 0.46900934 |
| 124 | MAP2K3 | 0.46668151 |
| 125 | ERN1 | 0.46333383 |
| 126 | CDK4 | 0.46276231 |
| 127 | OXSR1 | 0.45686512 |
| 128 | BCR | 0.45650238 |
| 129 | OBSCN | 0.44274132 |
| 130 | ABL1 | 0.44119091 |
| 131 | MAP2K6 | 0.44041569 |
| 132 | DAPK2 | 0.43690472 |
| 133 | TTK | 0.43174000 |
| 134 | TAOK3 | 0.43146873 |
| 135 | PAK3 | 0.42965142 |
| 136 | DAPK1 | 0.41687620 |
| 137 | CSNK2A2 | 0.40713835 |
| 138 | MST4 | 0.39752763 |
| 139 | TIE1 | 0.39203905 |
| 140 | MAP3K8 | 0.39195995 |
| 141 | MAP3K3 | 0.35753523 |
| 142 | LIMK1 | 0.34113478 |
| 143 | BRD4 | 0.31851708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.80337276 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.18228987 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.98168531 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69096183 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.45700424 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.43712893 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.36570421 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.28174876 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.27736622 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.24296644 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.20366147 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18724261 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14188132 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.14122252 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.97857882 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.94329603 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.91105514 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.89812441 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.81658809 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77735615 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.70042243 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.68804172 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63199112 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.63042222 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59271190 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58820070 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57621204 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.55944503 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55097718 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.47342402 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45367291 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.45367197 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.44117077 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.43582136 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.42082453 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40311999 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.38056070 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35108644 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34879662 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33969871 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.30699059 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26184923 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25435273 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22874613 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14238017 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14198344 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13873044 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 1.13372315 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13062258 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12088832 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.11320582 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.09730384 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08709472 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.08343438 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07590054 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06327919 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05932675 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05700437 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02616766 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02404545 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00268607 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99926556 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99329973 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.97965269 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97757602 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96499771 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93407057 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92003136 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91592244 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90920861 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89271117 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87385236 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86481151 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85804054 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84931619 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84735250 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84567441 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83482729 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82382058 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78610062 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76916455 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76489461 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75255548 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74841276 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74727050 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73440519 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72344111 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71642937 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69984887 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69333526 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68613906 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67999328 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66957995 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65855665 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65802779 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.65415013 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63565640 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62397485 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62295089 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.62247096 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60634252 |
| 102 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58941128 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58825396 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57515157 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.54223235 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54217982 |
| 107 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54057153 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53342424 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51874844 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50050905 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48785159 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48338498 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47988599 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47863649 |
| 115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47798434 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47617512 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47282318 |
| 118 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44733575 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.44453882 |
| 120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44305282 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44191686 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44145119 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.42949418 |
| 124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42874012 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41788122 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41665893 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41561156 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40810246 |
| 129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39660002 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39658519 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38580266 |
| 132 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38529883 |
| 133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37496441 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37474512 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.35134897 |

